| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |